AI helps classify prostate cancer using MRI images
Part of Cancer, Kidney & urinary clinical trials.
This trial studies whether a computer (AI) can better sort MRI results to improve prostate cancer diagnosis or classification. You may benefit by getting your multi-part MRI looked at in a new, more precise way, while helping researchers refine decision-making.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a person assigned male at birth and age 18 or older
- You either have concerning signs for prostate cancer or prostate cancer confirmed by biopsy
- You are able to have (or have already had) a multi-part prostate MRI using a 3 Tesla scanner at UCLA
- You can understand the study and sign consent
- You do not have reasons you cannot safely do an MRI (for example, certain implanted heart devices or severe claustrophobia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an artificial intelligence (AI) program to read MRI scans of the prostate and compare its findings with those of expert radiologists. The goal is to see if the AI can detect prostate cancer as accurately as the human experts, which might help in future diagnosis and treatment planning.
This trial uses MRI scans to study prostate lesions and see how they relate to diagnosis, pathology, and long-term outcomes. It may help patients with concerns about prostate health get more detailed imaging.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
This study tests whether artificial intelligence can help doctors read prostate MRI scans more accurately, which may improve cancer detection and treatment guidance. It aims to see if AI can assist in identifying suspicious areas without needing a biopsy first.
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.